These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7826548)
1. Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Tobian L; Brunner HR; Cohn JN; Gavras H; Laragh JH; Materson BJ; Weber MA Am J Hypertens; 1994 Oct; 7(10 Pt 1):859-72. PubMed ID: 7826548 [TBL] [Abstract][Full Text] [Related]
2. JNC-7 guidelines: are they still relevant? Cushman WC Curr Hypertens Rep; 2007 Nov; 9(5):380-6. PubMed ID: 18177584 [TBL] [Abstract][Full Text] [Related]
3. The Role of Beta-Blockers in the Treatment of Hypertension. Cruickshank JM Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711 [TBL] [Abstract][Full Text] [Related]
4. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension. Thomas GN; Chan P; Tomlinson B Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636 [TBL] [Abstract][Full Text] [Related]
5. The rationale for differing national recommendations for the treatment of hypertension. Ramsay LE; Wallis EJ; Yeo WW; Jackson PR Am J Hypertens; 1998 Jun; 11(6 Pt 2):79S-88S; discussion 95S-100S. PubMed ID: 9655567 [TBL] [Abstract][Full Text] [Related]
6. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance. Guo JD; Liu GG; Christensen DB; Fu AZ Value Health; 2003; 6(1):18-28. PubMed ID: 12535235 [TBL] [Abstract][Full Text] [Related]
7. Current treatment of patients with hypertension: therapeutic implications of INSIGHT. Taddei S; Ghiadoni L; Salvetti A Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362 [TBL] [Abstract][Full Text] [Related]
9. Current recommendations for the treatment of hypertension: are they still valid? Moser M J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197 [TBL] [Abstract][Full Text] [Related]
10. Clinical overview of antihypertensive classes--clinically relevant differences: myths or facts? Based on a presentation by Alan H. Gradman, MD. Am J Manag Care; 2000 Mar; 6(4 Suppl):S197-210. PubMed ID: 10977460 [TBL] [Abstract][Full Text] [Related]
11. Medicaid prescriber compliance with Joint National Committee VI Hypertension Treatment Guidelines. Clause SL; Hamilton RA Ann Pharmacother; 2002 Oct; 36(10):1505-11. PubMed ID: 12243597 [TBL] [Abstract][Full Text] [Related]
12. How to use calcium antagonists in hypertension: putting the JNC-VI guidelines into practice. Joint National Committee for the Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Singh V; Christiana J; Frishman WH Drugs; 1999 Oct; 58(4):579-87. PubMed ID: 10551431 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive Drugs and Male Sexual Dysfunction: A Review of Adult Hypertension Guideline Recommendations. Al Khaja KA; Sequeira RP; Alkhaja AK; Damanhori AH J Cardiovasc Pharmacol Ther; 2016 May; 21(3):233-44. PubMed ID: 26450998 [TBL] [Abstract][Full Text] [Related]
14. Reducing the risk for coronary heart disease and stroke in hypertensives--comments on mechanisms for coronary protection and quality of life. Wikstrand J J Clin Pharm Ther; 1992 Feb; 17(1):9-29. PubMed ID: 1548319 [TBL] [Abstract][Full Text] [Related]
15. [Retrospective studies and prospects of therapy for hypertension]. Maisch B; Brilla C; Kruse T; Noll B; Bethge C Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697 [TBL] [Abstract][Full Text] [Related]
16. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C; Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [TBL] [Abstract][Full Text] [Related]